Navigation Links
Isis Reports Financial Results and Highlights for Third Quarter 2010
Date:11/4/2010

of tax-34-187,124Net income (loss)(12,454)(12,718)(47,265)169,000Net loss attributable to noncontrolling interest in Regulus Therapeutics Inc.-1,136-2,906Net income (loss) attributable to Isis Pharmaceuticals, Inc. common stockholders$(12,454)$(11,582)$(47,265)$171,906Basic and diluted net income (loss) per share:Net loss from continuing operations attributable to Isis Pharmaceuticals, Inc. common stockholders$(0.13)$(0.12)$(0.48)$(0.16)Net income from discontinued operations---1.91Basic and diluted net income (loss) attributable to Isis Pharmaceuticals, Inc. common stockholders$(0.13)$(0.12)$(0.48)$1.75Shares used in computing basic and diluted net income (loss) per share99,19698,32099,10197,988(1)  During the preparation of the year end 2009 annual tax provision, Isis determined that certain tax items had been attributed to discontinued operations that are appropriately associated with continuing operations.  As a result, Isis revised the tax provisions reflected in each of the first three quarters during 2009 to reflect the correction of this allocation. The historical condensed consolidated statements of operations for the three and nine months ended September 30, 2009 reflect the revised tax provisions.Isis Pharmaceuticals, Inc.Reconciliation of Isis' 2009 Statement of OperationsAdjusted for Regulus Therapeutics Inc.(In Thousands, Except Per Share Data)(unaudited)Nine months ended September 30, 2009(as reported)Adjustments for Regulus(1)Nine months ended September 30, 2009(as adjusted)Revenue:Research and development revenue under collaborative agreements $86,415$(2,388)$84,027Licensing and royalty revenue2,924-2,924Total revenue89,339(2,388)86,951Expenses:Research and development 94,519(6,282)88,237General and administrative 10,685(1,982)8,703Total operating expenses105,204(8,264)96,940Loss from operations(15,865)5,876(9,989)Other income (expense):Equity in net loss of Regul
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. Tapestry Reports Second Quarter 2007 Results
4. Callisto Reports on Second-Quarter 2007 Milestones
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
9. Biopure Reports on Meeting with the FDA
10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... 2014 WuXi PharmaTech (Cayman) Inc. (NYSE: ... platform company serving the pharmaceutical, biotechnology, and medical device ... and the United States , today ... Tel Aviv area of Israel.  ... broad platform of integrated R&D services to local customers. ...
(Date:10/30/2014)...   ViaDerma, Inc. (OTCQB: VDRM), a ... to market, has recently released a revolutionary new ... topical liquid tetracycline-based antibiotic that uses a patent-pending ... medication active ingredients into topical drugs. The drug ... to help prevent skin infection in minor cuts, ...
(Date:10/30/2014)... , Oct. 30, 2014 Molecular Profiles Ltd., ... CBRX ) and Maryland -based Xceleron ... improved efficiency during clinical development that will be launched ... next week. This partnership extends Molecular Profiles, ... it launched earlier this month. The company also has ...
Breaking Medicine Technology:WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 3Molecular Profiles To Launch US Strategic Alliance At AAPS 2Molecular Profiles To Launch US Strategic Alliance At AAPS 3
(Date:10/30/2014)... Toronto, Canada (PRWEB) October 30, 2014 ... the area’s leading provider of non-medical, in-home senior care, ... activity to increased brain health. , The study, performed ... the ages of 60 and 78 over a week-long ... as opposed to daily physical activity. By examining the ...
(Date:10/30/2014)... REV'D Provision Co. announced today that REV’D® ... unique service called, The Feed . The Feed ... athlete. The Feed has taken the nutritional knowledge used ... to pass that information on to the everyday athlete. ... on The Feed!” says REV’D® marketing manager Matt O’Connor. ...
(Date:10/30/2014)... (HealthDay News) -- When it comes to heart disease, a ... delay care when they have symptoms that spell trouble. ... hospital with a more severe or advanced stage of heart ... Catherine Kreatsoulas, a Fulbright Scholar and research fellow at the ... from the Heart and Stroke Foundation of Canada. In ...
(Date:10/30/2014)... -- Eating a low-carb, high-fat diet could help control ... research. A review of five studies found ... on foods like bacon, eggs, heavy cream, butter, fish ... whose condition doesn,t improve with medication. "We need ... epilepsy whose seizures are not stopped by medications," study ...
(Date:10/29/2014)... of minimally and even non-invasive technologies is increasing in ... to carry out a range of operative procedures using ... only tiny scars as a result. Similar opportunities are ... to patients – instead of using injections or probes ... to supply them via a plaster which continuously, gently ...
Breaking Medicine News(10 mins):Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 2Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 3Health News:Nutrition Experts at TheFeed.com Get REV'D 2Health News:Nutrition Experts at TheFeed.com Get REV'D 3Health News:Women Often Ignore Signs of Heart Trouble 2Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 2Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 3Health News:Gentle caffeine boost for premature babies 2
... 20 Cord Blood America, Inc., (OTC Bulletin Board: ... storage company, has selected Somerville Associates, a 25 year-old ... public relations counsel for Cord Blood America, Inc., according ... Blood America. The agency will publicize Cord Blood ...
... Reflex Plus surgical microscope from Endure Medical, Inc. represents a new ... ... March 20, 2009 -- Endure Medical ( www.enduremed.com ) has created ... excellent optical quality, exceptional red reflex and a price that is ...
... a Silver 2009 ADDY® Award for its multi-media drug education and prevention ... new public service announcements. , ... Los Angeles, Ca (PRWEB) March 19, ... 30 to 60 seconds in duration, brings home the stark reality of ...
... hip- or knee-replacement surgery , , , THURSDAY, March ... blood-thinning drug rivaroxaban outweigh its risks, a U.S. Food ... (Xarelto) could be one of the long-sought alternatives to ... patients. , The panel voted 15 to 2 in ...
... group homes in Los Angeles County after being charged with ... or drugs seven years later, according to a new RAND ... need to improve juvenile justice rehabilitation programs, according to the ... Health . , Studies rarely track juvenile offenders for so ...
... Today, South Dakota residents have reason to celebrate. ... in the nation, and the first in 2009 to ... from secondhand smoke, in both public places and at ... making great strides in protecting health and saving lives ...
Cached Medicine News:Health News:Cord Blood America, Inc. Appoints Somerville Associates, Public Relations Counsel 2Health News:Endure Medical Redefines Ophthalmic Surgical Microscopes 2Health News:Foundation for the Drug-Free World Honored with Seven ADDY Awards 2Health News:FDA Panel Backs New Anti-Clotting Drug 2Health News:Study finds most adolescents sent to group homes still involved with drugs/crime seven years later 2
... prisms are of superior quality. Set of 16 includes 1/2, ... 35, 40, 45, and 50 diopter plus Red Lens. Each ... lbs)., , 4445xx , ,These prisms are of superior quality. ... 6, 7, 8, 9, 10, 12, 14, 16, 18, 20, ...
Force 1C has a streamlined, compact design perfect for the requirements of outpatient surgery - as well as the power and performance features needed for a full range of general inpatient surgical pro...
... PC is the most powerful Isolated ESU on ... It is the only ESU that allows the ... field with a standard ES pencil. Excalibur Plus ... minimum necessary voltage for smooth cutting through various ...
Diamond phaco knife keratome shaped blade straight. 3.2 mm wide....
Medicine Products: